Oral Session 3-8A Cord Blood Transplanation

[OS3-8A-2] Unit selection for umbilical cord blood transplantation for adults with AML in complete remission

Masamitsu Yanada¹, Takaaki Konuma², Yachiyo Kuwatsuka³, Tadakazu Kondo⁴, Takahito Kawata^4,5, Satoshi Takahashi², Naoyuki Uchida⁶, Shigesaburo Miyakoshi⁷, Masatsugu Tanaka⁸, Yukiyasu Ozawa⁹, Masashi Sawa¹⁰, Hirohisa Nakamae¹¹, Nobuyuki Aotsuka¹², Junya Kanda⁴, Minoko Takanashi¹³, Yoshinobu Kanda¹⁴, Yoshiko Atsuta^15,16, Shingo Yano¹⁷ (1.Aichi Cancer Center, Nagoya, 2.The Institute of Medical Science, The University of Tokyo, Tokyo, 3.Nagoya University Hospital, Nagoya, 4.Graduate School of Medicine, Kyoto University, Kyoto, 5.Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, 6.Toranomon Hospital, Tokyo, 7.Tokyo Metropolitan Geriatric Hospital, Tokyo, 8.Kanagawa Cancer Center, Yokohama, 9.Japanese Red Cross Nagoya First Hospital, Nagoya, 10.Anjo Kosei Hospital, Anjo, 11.Graduate School of Medicine, Osaka City University, Osaka, 12.Japanese Red Cross Narita Hospital, Narita, 13.Japanese Red Cross Society, Tokyo, 14.Jichi Medical University, Shimotsuke, 15.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, 16.Nagoya University Graduate School of Medicine, Nagoya, 17.The Jikei University School of Medicine, Tokyo)